Jue Joshua S, Mikhail David, González Javier, Alameddine Mahmoud
Department of Urology, Lenox Hill Hospital, Northwell Health, Zucker School of Medicine at Hofstra/Northwell, New York, NY 10028, USA.
Department of Urology, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.
Diagnostics (Basel). 2021 Jul 5;11(7):1213. doi: 10.3390/diagnostics11071213.
Prostate-specific antigen (PSA) has been criticized for its low specificity for prostate cancer, which has led to the increased adoption of additional biomarkers, PSA density (PSAD), and multiparametric magnetic resonance imaging (mpMRI) to increase the localization, risk stratification, and diagnosis of prostate cancer [...].
前列腺特异性抗原(PSA)因其对前列腺癌的低特异性而受到批评,这导致更多地采用其他生物标志物、前列腺特异抗原密度(PSAD)和多参数磁共振成像(mpMRI)来提高前列腺癌的定位、风险分层和诊断水平[...]。